AURINIA PHARMACEUTICALS INC (AUPH) Stock Income Statement
NASDAQ:AUPH - Nasdaq - CA05156V1022 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 247.29M | 235.13M | 175.51M | 134.00M | 45.60M | |||
| Cost Of Goods | 29.07M | 28.25M | 14.15M | 5.70M | 1.10M | |||
| Gross Profit | 218.22M | 206.88M | 161.37M | 128.40M | 44.50M | |||
| Operating Expenses | 169.86M | 188.47M | 253.06M | 239.80M | 225.20M | |||
| Research and Development | 20.98M | 20.79M | 49.64M | 45.00M | 51.10M | |||
| Selling, General, and Administrative Expenses | 144.67M | 172.03M | 195.04M | 196.40M | 171.40M | |||
| Operating Income | 48.37M | 18.42M | -91.69M | -111.50M | -180.70M | |||
| Interest Income/Expense | 11.39M | 12.13M | 14.22M | 5.10M | 500.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -17.96M | -23.11M | N/A | N/A | N/A | |||
| Income Before Taxes | 41.81M | 7.45M | -77.47M | -106.40M | -180.20M | |||
| Income Tax | 1.96M | 1.70M | 551.00K | 1.80M | 800.00K | |||
| Net Income | 39.84M | 5.75M | -78.02M | -108.20M | -181.00M | |||
| EBITDA | 67.82M | 37.86M | -80.04M | -108.79M | -177.94M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.28 | 0.04 | -0.54 | -0.76 | -1.40 | |||
| Non GAAP EPS | 0.28 | 0.09 | -0.54 | -0.76 | -1.41 | |||
| Statistics | ||||||||
| Gross Profit Margin | 88.24% | 87.99% | 91.94% | 95.82% | 97.59% | |||
| Profit Margin | 16.11% | 2.45% | -44.45% | -80.75% | -396.93% | |||
| Operating Profit Margin | 19.56% | 7.83% | -52.24% | -83.21% | -396.27% | |||
All data in USD